Conditions: Alzheimer's Disease
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 41
Healthy volunteers: no

Brief summary:
This is a Phase II, Single-Blind, Placebo-Controlled, Sequential Treatment, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of CPC-201 in Patients with Alzheimer's Disease Type Dementia.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: CPC-201
Intervention descriptions: intervention 1: None

Protocol document: